Stock Movers

On this episode of Stock Movers:
- SpaceX (SPCX) shares slipped for a third straight day after the company said it is selling investment-grade bonds for the first time to fund its artificial-intelligence ambitions. The company is seeking to raise at least $20 billion from the first bond offering, according to Bloomberg.
- Micron (MU) shares gain. Micron entered into a strategic agreement with Anthropic that includes memory and storage AI architecture design collaboration, a supply agreement, enterprise AI adoption and a strategic investment in Anthropic’s Series H funding round.
- Alphabet (GOOGLE) shares drop. The departure of John Jumper from Google DeepMind for Anthropic is contributing to a dip in the communication services sector. Jumper was one of two DeepMind scientists who won the Nobel Prize in chemistry in 2024 for using AI to predict protein structures.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics. That's also according to a Financial Times report.
- Regenxbio (RGNX) shares are moving on news Regenxbio aligned with the FDA on next steps for a potential accelerated approval of Navsunli, a gene therapy for Mucopolysaccharidosis II, with the FDA confirming the company doesn’t need to conduct additional studies of the drug.
- SpaceX (SPCX) is lower this morning, continuing its slide after its record IPO.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Arcosa (ACA) are rising on news building materials group CRH is close to its biggest deal ever to acquire competitor Arcosa, and an agreement could come as soon as next week, the Financial Times reports, citing people familiar with the matter. Arcosa currently has a market capitalization close to $7 billion, and with its debt the company’s price could be more than $8 billion, the Financial Times reported.
- Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics. That's also according to a Financial Times report.
- Getty Images (GETY) is jumping as it announces a display partnership with OpenAI.
- Micron (MU) is higher on momentum from the AI trade. It will report earnings Wednesday.
- SpaceX (SPCX) is lower this morning, continuing its slide after its record IPO.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- EasyJet shares rise as much as 5.4% to the highest level in almost a year after the British budget carrier rejected a third takeover proposal from US investment firm Castlelake.
- Carrefour is resumed with an overweight rating and Street-high €20.1 price target at Morgan Stanley, which says the French supermarket operator’s strategic plan is being undervalued.
- Babcock kept its guidance unchanged on Monday as it announced a 21% fall in annual adjusted pretax profit to £267 million ($353 million), a result that missed analysts’ estimates. Shares dropped as much as 5.1% in early London trading on Monday.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- EasyJet shares rise as much as 5.4% to the highest level in almost a year after the British budget carrier rejected a third takeover proposal from US investment firm Castlelake.
- Carrefour is resumed with an overweight rating and Street-high €20.1 price target at Morgan Stanley, which says the French supermarket operator’s strategic plan is being undervalued.
- Infineon climbs as much as 5% just days after the firm on two patent infringement cases against Innoscience in a German court, which prohibited the Chinese company from manufacturing, selling and marketing additional patent-infringing gallium nitride products in Germany and ordered it to pay damages, according to statement.
See omnystudio.com/listener for privacy information.